secukinumab,adalimumab
novartis,abbvie
['ec 18', 'adalimumab', 'axspa', 'crohn', 'ulcerative colitis', 'secukinumab', 'surpass', 'arca, (-arcade)']
don't miss the key takeaways as current president and president-elect unveils the long-awaited first bdmard h2h data in axspa from the surpass study. the moment we've been eagerly waiting for is here! #eular2023 #rheumatology 
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official @EULAR_ORG journals. High quality, peer reviewed research.